Molecular Features of Metaplastic Breast Carcinoma: An Infrequent Subtype of Triple Negative Breast Carcinoma
Open Access
Abstract
Metaplastic breast carcinoma (MBC) is a heterogeneous group of infrequent invasive carcinomas that display differentiation of the neoplastic epithelium towards squamous cells and/or mesenchymal-type elements. Most MBC have a triple negative phenotype and poor prognosis. Thus, MBC have worse survival rates than other invasive breast carcinomas, including other triple negative breast carcinomas (TNBC). In this study, we reviewed the molecular features of MBC, pointing out the differences among subtypes. The most frequently mutated genes in MBC were TP53 and PIK3CA. Additionally, mutations in the other genes of the PI3K/AKT pathway indicated its importance in the pathogenesis of MBC. Regarding copy number variations (CNVs), MYC was the most frequently amplified gene, and the most frequent gene loss affected the CDKN2A/CDKN2B locus. Furthermore, the pattern of mutations and CNVs of MBC differed from those reported in other TNBC. However, the molecular profile of MBC was not homogeneous among histological subtypes, being the alterations in the PI3K pathway most frequent in spindle cell carcinomas. Transcriptomic studies have demonstrated an epithelial to mesenchymal program activation and the enrichment of stemness genes in most MBC. In addition, current studies are attempting to define the immune microenvironment of these tumors. In conclusion, due to specific molecular features, MBC have a different clinical behavior from other types of TNBC, being more resistant to standard chemotherapy. For this reason, new therapeutic approaches based on tumor molecular characteristics are needed to treat MBC.Keywords
Funding Information
- Instituto de Salud Carlos III (PI19/01331)
- Centro de Investigación Biomédica en Red de Cáncer (CB16/12/00316, CB16/12/00449)
This publication has 86 references indexed in Scilit:
- Unique clinicopathological features of metaplastic breast carcinoma compared with invasive ductal carcinoma and poor prognostic indicatorsWorld Journal of Surgical Oncology, 2013
- Expression of tissue levels of matrix metalloproteinases and tissue inhibitors of metalloproteinases in renal cell carcinomaWorld Journal of Surgical Oncology, 2013
- MicroRNA-200 Family Modulation in Distinct Breast Cancer PhenotypesPLOS ONE, 2012
- Metaplastic breast carcinomas are enriched in markers of tumor-initiating cells and epithelial to mesenchymal transitionLaboratory Investigation, 2011
- A deleterious BRCA1 mutation in a young Pakistani woman with metaplastic breast carcinomaPathology - Research and Practice, 2011
- Core epithelial-to-mesenchymal transition interactome gene-expression signature is associated with claudin-low and metaplastic breast cancer subtypesProceedings of the National Academy of Sciences, 2010
- Epithelial-Mesenchymal Transitions in Development and DiseaseCell, 2009
- Genetic Changes of Wnt Pathway Genes Are Common Events in Metaplastic Carcinomas of the BreastClinical Cancer Research, 2008
- Epithelial-Mesenchymal Transition in Breast Cancer Relates to the Basal-like PhenotypeCancer Research, 2008
- Metaplastic carcinoma of the breast, an unusual disease with worse prognosis: the experience of the European Institute of Oncology and review of the literatureBreast Cancer Research and Treatment, 2006